Natural approaches for optimal sleep

Alternative and Complementary Therapies

Volumn 14, Issue 4, 2008, Pages 181-188

  Meletis, Chris D ^a,b   Zabriskie, Nieske ^c  

^a Institute for Healthy Aging   (United States)

^b National College of Natural Medicine   (United States)

^c NONE

Author keywords

[No Author keywords available]

Indexed keywords

EID: 49949108246     PISSN: 10762809     EISSN: None     Source Type: Journal    
DOI: 10.1089/act.2008.14402     Document Type: Article

References (63)

1. Pearson NJ, Johnson LL, Nahin RL. Insomnia, trouble sleeping, and complementary and alternative medicine: Analysis of the 2002 national health interview survey data. Arch Intern Med 2006;166:1775-1782.
2. Peters KR, Ray L, Smith V, et al. Changes in the density of stage 2 sleep spindles following motor learning in young and older adults. J Sleep Res 2008;17:23-33.
3. Wagner U, Born J. Memory consolidation during sleep: Interactive effects of sleep stages and HPA regulation. Stress July 20, 2007;1:epub ahead of print.
4. Roth T. Insomnia: Definition, prevalence, etiology, and consequences. J Clin Sleep Med 2007;3(suppl):S7-S10.
5. Doghramji K. The epidemiology and diagnosis of insomnia. Am J Manag Care 2006;12(suppl):S214-S220.
6. Hidalgo JL, Gras CB, García YD, et al. Functional status in the elderly with insomnia. Qual Life Res 2007;16:279-286.
7. Power JD, Perruccio AV, Badley EM. Pain as a mediator of sleep problems in arthritis and other chronic conditions. Arthritis Rheum 2005;53:911-919.
8. Ohayon MM. Relationship between chronic painful physical condition and insomnia. J Psychiatr Res 2005;39:151-159.
9. Wetzler RG, Window DH. New solutions for treating chronic insomnia: An introduction to behavioral sleep medicine. J Ky Med Assoc 2006;104:502-512.
10. Cotter PE, O'Keeffe ST. Restless leg syndrome: Is it a real problem? Ther Clin Risk Manag 2006;2:465-475.
11. Mizuno S, Mihara T, Miyaoka T, et al. CSF iron, ferritin and transferrin levels in restless legs syndrome. J Sleep Res 2005;14:43-47.
12. Lavie P. Insomnia and sleep-disordered breathing. Sleep Med 2007;8(suppl):S21-S25.
13. Fletcher EC. Obstructive sleep apnoea and cardiovascular morbidity. Monaldi Arch Chest Dis 1996;51:77-80.
14. Young T, Palta M, Dempsey J, et al. The occurrence of sleep-disordered breathing among middle-aged adults. N Engl J Med 1993;328:1230-1235.
15. Ancoli-Israel S, Kripke DF, Mason W. Characteristics of obstructive and central sleep apnea in the elderly: An interim report. Biol Psychiatry 1987;22:741-750.
16. Ancoli-Israel S, Klauber MR, Stepnowsky C, et al. Sleep-disordered breathing in African American elderly. Am J Respir Crit Care Med 1995;152:1946-1949.
17. Schafer H, Pauleit D, Sudhop T, et al. Body fat distribution, serum lep tin, and cardiovascular risk factors in men with obstructive sleep apnea. Chest 2002;122:829-839.
18. Resta O, Pannacciulli N, Di Gioia G, et al. High prevalence of previously unknown subclinical hypothyroidism in obese patients referred to a sleep clinic for sleep disordered breathing. Nutr Metab Cardiovasc Dis 2004;14:248-253.
19. Resta O, Bonfitto P, Sabato R, et al. Prevalence of obstructive sleep apnoea in a sample of obese women: Effect of menopause. Diabetes Nutr Metab 2004;17:296-303.
20. Punjabi NM. The epidemiology of adult obstructive sleep apnea. Proc Am Thorac Soc 2008;5:136-143.
21. Roth T. Prevalence, associated risks, and treatment patterns of insomnia. J Clin Psychiatry 2005;66:10-13.
22. Ohayon MM, Roth T. Place of chronic insomnia in the course of depressive and anxiety disorders. J Psychiatr Res 2003;37:9-15.
23. Banks S, Dinges DF. Behavioral and physiological consequences of sleep restriction. J Clin Sleep Med 2007;3:519-528.
24. Kuppermann M, Lubeck DP, Mazonson PD, et al. Sleep problems and their correlates in a working population. J Gen Intern Med 1995;10:25-32.
25. Perez-Chada D, Videla AJ, O'Flaherty ME, et al. Sleep habits and accident risk among truck drivers: a cross-sectional study in Argentina. Sleep 2005;28:1103-1108.
26. Sagberg F. Driver health and crash involvement: A case-control study. Accid Anal Prev 2006;38:28-34.
27. Jefferson CD, Drake CL, Scofield HM, et al. Sleep hygiene practices in a population-based sample of insomniacs. Sleep 2005;28:611-615.
28. Dollander M. Etiology of adult insomnia. Encephale 2002;28:493-502.
29. Roth T, Roehrs T, Pies R. Insomnia: Pathophysiology and implications for treatment. Sleep Med Rev 2007;11:71-79.
30. Rodenbeck A, Huether G, Rüther E, et al. Interactions between evening and nocturnal Cortisol secretion and sleep parameters in patients with severe chronic primary insomnia. Neurosa Lett 2002;324:159-163.
31. Vgontzas AN, Bixler EO, Lin HM, et al. Chronic insomnia is associated with nyctohemeral activation of the hypothalamic-pituitary-adrenal axis: Clinical implications. J Clin Endocrinol Metab 2001;86:3787-3794.
32. Bonnet MH, Arand DL. 24-Hour metabolic rate in insomniacs and matched normal sleepers. Sleep 1995;18:581-588.
33. Salín-Pascual RJ, Valencia-Flores M, Campos RM, et al. Caffeine challenge in insomniac patients after total sleep deprivation. Sleep Med 2006;7:141-145.
34. Pandi-Perumal SR, Srinivasan V, Spence DW, el al. Role of the melatonin system in the control of sleep: Therapeutic, implications. CNS Drugs 2007;21:995-1018.
35. Brzezinski A, Vangel MG, Wurtman RJ, et al. Effects of exogenous melatonin on sleep: A meta-analysis. Sleep Med Rev 2005;9:41-50.
36. Van der Heijden KB, Smits MG, Van Someren EJ, et al. Effect of melatonin on sleep, behavior, and cognition in ADHD and chronic sleep-onset insomnia. J Am Acad Child Adolesc Psychiatry 2007;46:233-241.
37. Suresh Kumar PN, Andrade C, Bhakta SG, et al. Melatonin in schizophrenic outpatients with insomnia: A double-blind, placebo-controlled study. J Clin Psychiatry 2007;68:237-241.
38. Wade AG, Ford I, Crawford G, et al. Efficacy of prolonged release melatonin in insomnia patients aged 55-80 years: Quality of sleep and next-day alertness outcomes. Curr Med Res Opin 2007;23:2597-2605.
39. Birdsall TC. 5-Hydroxytryptophan: A clinically-effective serotonin precursor. Altern Med Rev 1998;3:271-280.
40. Hartmann E. Effects of L-tryptophan on sleepiness and on sleep. J Psychiatr Res 1982-1983;17:107-113.
41. Riemann D, Feige B, Hornyak M, et al. The tryptophan depletion test: Impact on sleep in primary insomnia - a pilot study. Psychiatry Res 2002;109:129-135.
42. Spinweber CL. L-Tryptophan administered to chronic sleep-onset insomniacs: Late-appearing reduction of sleep latency. Psychopharmacology (Berl) 1986;90:151-155.
43. Demisch K, Bauer J, Georgi K. Treatment of severe chronic insomnia with L tryptophan and varying sleeping times. Pharmacopsychiatry 1987;20:245-248.
44. Lu K, Gray MA, Oliver C, et al. The acute effects of L theanine in com parison with alprazolam on anticipatory anxiety in humans. Hum Psychopharmacol 2004;19:457-465.
45. Nathan PJ, Lu K, Gray M, et al.The neuropharmacology of L-theanine (N-ethyl-L-glutamine): A possible neuroprotective and cognitive enhancing agent. J Herb Pharmacother 2006;6:21-30.
46. L-theanine: Monograph. Altern Med Rev 2005;10:136-138.
47. Yamada T, Terashima T, Okubo T, et al. Effects of theanine, R-glutamyl-ethylamide, on neurotransmitter release and its relationship with glutamic acid neurotransmission. Nutr Neurosa 2005;8:219-226.
48. Kimura K, Ozeki M, Juneja LR, et al. L-Theanine reduces psychological and physiological stress responses. Biol Psychol 2007;74:39-45.
49. Abdou AM, Higashiguchi S, Horie K, et al. Relaxation and immunity enhancement effects of gamma-aminobutyric acid (GABA) administration in humans. Biofactors 2006;26:201-208.
50. Ebihara S, Mano N, Kurono N, et al. Vitamin B12 affects non-photic entrainment of arcadian locomotor activity rhythms in mice. Brain Res 1996;727:31-39.
51. Patrick LR. Restless legs syndrome: Pathophysiology and the role of iron and folate. Altern Med Rev 2007;12:101-112.
52. Hornyak M, Voderholzer U, Hohagen F, et al. Magnesium therapy for periodic leg movements-related insomnia and restless legs syndrome: An open pilot study. Sleep 1998;21:501-505.
53. Poleszak E, Szewczyk B, Kedzierska E, et al. Antidepressant- and anxiolytic like activity of magnesium in mice. Pharmacol Biochem Behav 2004;78:7-12.
54. Yuan CS, Mehendale S, Xiao Y, et al. The gamma aminobutyric acidergic effects of valerian and valerenic acid on rat brainstem neuronal activity. Anesth Analg 2004;98:353-358.
55. Ziegler G, Ploch M,Miettinen-Baumann A,et al. Efficacy and tolerability of valerian extract LI 156 compared with oxazepam in the treatment of non-organic insomnia a randomized, double blind, comparative clinical study. Eur J Med Res 2002;7:480-486.
56. Leathwood PD, Chauffard F, Heck E, et al. Aqueous extract of valerian root (Valeriana officinalis L.) improves sleep quality in man. Pharmacol Biochem Behav 1982;17:65-71.
57. Donath F, Quispe S, Diefenbach K, et al. Critical evaluation of the effect of valerian extract on sleep structure and sleep quality. Pharmacopsychiatry 2000;33:47-53.
58. Fussel A, Wolf A, Brattstrom A. Effect of a fixed valerian-hop extract combination (Ze 91019) on sleep polygraphy in patients with non-organic insomnia: A pilot study. Eur J Med Res 2000;5:385-390.
59. Kennedy DO, Scholey AB,Tildesley NT, et al. Modulation of mood and cognitive performance following acute administration of Melissa officinalis (lemon balm). Pharmacol Biochem Behav 2002;72:953-964.
60. Burns A, Byrne J, Ballard C, Holmes C. Sensory stimulalion in dementia. Br Med J 2002;325:1312-1313.
61. Cerny A, Shmid K. Tolerability and efficacy of valerian/lemon balm in healthy volunteers (a double blind, placebo controlled, multicentre study). Fitoterapia 1999;70:221-228.
62. Müller SF, Klement S. A combination of valerian and lemon balm is effective in the treatment of restlessness and dyssomnia in children. Phytomedicine 2006;13:383-387.
63. Akhondzadch S, Naghavi HR, Vazirian M, et al. Passionflower in the treatment of generalized anxiety: A pilot double-blind randomized controlled trial with oxazepam. J Clin Pharm Ther 2001;26:363-367.